MP1 Activators
MP1 Activators are a distinct category of chemical compounds that enhance the functional activity of a protein known as MP1 through precise biochemical mechanisms. This class of activators works by engaging with various signaling pathways that are intrinsically linked to the regulatory functions of MP1. For instance, a subset of these activators may target secondary messenger systems, modulating intracellular concentrations of key molecules like cAMP or calcium ions. This modulation can lead to the activation of kinases or phosphatases that directly or indirectly stimulate MP1's activity. Another group within the MP1 Activators may interact with membrane receptors or ion channels, leading to altered membrane potential or cellular homeostasis, which in turn can affect the activity of MP1 through downstream signaling cascades. These activators often have the ability to either enhance the binding efficacy of MP1 to its substrates or increase its catalytic action, thus amplifying the protein's biological functions.
The efficacy of MP1 Activators is further exemplified by their interaction with specific transcription factors that control the expression of MP1 or its associated partners within the cell. By influencing these transcription factors, MP1 Activators can indirectly elevate the functional presence of MP1, ensuring that the protein's activity levels meet the cellular demands. It is also noteworthy that some members of this chemical class can alter the phosphorylation state of MP1 through the inhibition or activation of upstream kinases or phosphatases. Such changes in phosphorylation can lead to conformational shifts in MP1, which may enhance its stability and interaction with other proteins, thereby promoting its activity. Collectively, MP1 Activators are characterized by their nuanced and varied approaches to upregulating the activity of MP1, each affecting different aspects of the protein's regulatory mechanisms to ensure an overall increase in its biological function within the context of cellular physiology.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylyl cyclase, increasing intracellular cAMP. Elevated cAMP activates PKA, which can then phosphorylate MP1, enhancing its scaffolding function within the MAPK signaling pathway. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-selective inhibitor of phosphodiesterases, which prevents cAMP degradation, indirectly supporting cAMP-dependent activation of PKA that may enhance MP1 activity by promoting its interaction with MAPK pathway components. | ||||||
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $65.00 $280.00 $400.00 | 48 | |
AICAR activates AMPK, which can modulate the mTOR pathway, indirectly leading to enhanced MP1 activity within the mTORC1 complex through its scaffolding functions. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC) which can phosphorylate proteins that interact with MP1, potentially enhancing its role in MAPK pathway signaling. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic Acid is an inhibitor of protein phosphatases PP1 and PP2A, leading to increased phosphorylation levels within cellular proteins, which might enhance MP1's interaction with MAPK signaling molecules due to altered phosphorylation dynamics. | ||||||
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $41.00 $74.00 $221.00 $247.00 $738.00 $1220.00 | 39 | |
Paclitaxel stabilizes microtubules and can affect signaling pathways related to cell division and stress response, potentially enhancing MP1's role in signaling pathways that are active during cell division. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that can alter the activity of downstream signaling pathways, including those involving MP1, by modulating the localization and activity of MP1 within the mTORC1 complex. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin binds FKBP12 and inhibits mTORC1, which may lead to a compensatory increase in MP1 activity as part of the cellular feedback mechanism to maintain signaling homeostasis. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol activates SIRT1, which may deacetylate proteins in the mTOR pathway, potentially leading to enhanced MP1 activity through its effects on the mTORC1 complex and related signaling. | ||||||
Zoledronic acid, anhydrous | 118072-93-8 | sc-364663 sc-364663A | 25 mg 100 mg | $92.00 $256.00 | 5 | |
Zoledronic Acid inhibits farnesyl pyrophosphate synthase, leading to reduced protein prenylation. This could affect the localization and function of proteins interacting with MP1, potentially enhancing its role in signaling pathways. | ||||||